These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 26888346)
1. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas. Lim Y; Sun CX; Tran P; Punyadeera C Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346 [TBL] [Abstract][Full Text] [Related]
2. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma. Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258 [TBL] [Abstract][Full Text] [Related]
4. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas. Hwang S; Mahadevan S; Qadir F; Hutchison IL; Costea DE; Neppelberg E; Liavaag PG; Waseem A; Teh MT Cancer; 2013 Dec; 119(24):4249-58. PubMed ID: 24114764 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers. Wang Y; Wang J; Huang Y Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448 [TBL] [Abstract][Full Text] [Related]
6. Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance. Carvalho AL; Henrique R; Jeronimo C; Nayak CS; Reddy AN; Hoque MO; Chang S; Brait M; Jiang WW; Kim MM; Claybourne Q; Goldenberg D; Khan Z; Khan T; Westra WH; Sidransky D; Koch W; Califano JA Clin Cancer Res; 2011 Jul; 17(14):4782-9. PubMed ID: 21628494 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. Lallemant B; Evrard A; Combescure C; Chapuis H; Chambon G; Raynal C; Reynaud C; Sabra O; Joubert D; Hollande F; Lallemant JG; Lumbroso S; Brouillet JP BMC Cancer; 2009 Oct; 9():370. PubMed ID: 19835631 [TBL] [Abstract][Full Text] [Related]
8. [Epigenetic aspects in carcinomas of the head and neck]. Schmezer P; Plass C HNO; 2008 Jun; 56(6):594-602. PubMed ID: 18483718 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095 [TBL] [Abstract][Full Text] [Related]
10. Delineating an epigenetic continuum in head and neck cancer. Worsham MJ; Stephen JK; Chen KM; Havard S; Shah V; Gardner G; Schweitzer VG Cancer Lett; 2014 Jan; 342(2):178-84. PubMed ID: 22388100 [TBL] [Abstract][Full Text] [Related]
11. Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers. Drake RR; Cazare LH; Semmes OJ; Wadsworth JT Expert Rev Mol Diagn; 2005 Jan; 5(1):93-100. PubMed ID: 15723595 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic and predictive methylation biomarkers in HNSCC : Epigenomic diagnostics for head and neck squamous cell carcinoma (HNSCC)]. Franzen A; Bootz F; Dietrich D HNO; 2020 Dec; 68(12):911-915. PubMed ID: 32613323 [TBL] [Abstract][Full Text] [Related]
13. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335 [TBL] [Abstract][Full Text] [Related]
14. Methylation as a biomarker for head and neck cancer. Arantes LM; de Carvalho AC; Melendez ME; Carvalho AL; Goloni-Bertollo EM Oral Oncol; 2014 Jun; 50(6):587-92. PubMed ID: 24656975 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease. Gollin SM Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546 [TBL] [Abstract][Full Text] [Related]
16. Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review. Lim I; Tan J; Alam A; Idrees M; Brenan PA; Coletta RD; Kujan O J Oral Pathol Med; 2024 Feb; 53(2):90-106. PubMed ID: 38316046 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of head and neck squamous cell cancer biomarkers. Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422 [TBL] [Abstract][Full Text] [Related]
18. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. Lee KD; Lee HS; Jeon CH Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360 [TBL] [Abstract][Full Text] [Related]